Advertisement

Alpha-type B Cell Growth Factor and Complement Component C3: Their Possible Structural Relationship

  • Waldemar Lernhardt
  • William C. Raschke
  • Fritz Melchers
Conference paper
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 132)

Abstract

The third component of complement C3 has been found to control the entry of activated B cell blasts into the S-phase of the cell cycle (Erdei et al., 1985; Melchers et al., 1985). In its activity as a synergistic growth factor, it therefore replaces a-type B cell growth factors (BCGF; Corbel and Melchers, 1984) which have been found to act at the same temporal point (restriction point) in the cell cycle (Melchers and Lernhardt, 1985). Furthermore, soluble C3d inhibits the synergistic action of a-type BCGF (Melchers et al., 1985). These results have suggested that both C3 and a-type BCGF act by signalling through the C3d-specific complement receptor CR2 (Fearon, 1984). The growth regulating properties of the CR2 receptor for B cells have also been implied in studies which demonstrated stimulating activities of CR2-specific, monoclonal antibodies with human B cells (Nemerow et al, 1985). These results have prompted us to investigate whether a structural relationship exists between C3 and α-type BCGF.

Keywords

Cell Blast mRNA Species Xenopus Laevis Oocyte Scripps Research Institution mRNA Size 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Corbel C, Melchers F (1984) The synergism of accessory cells and of soluble α-factors derived from them in the activation of B cells to proliferation. Immunol Rev 78: 51–74PubMedCrossRefGoogle Scholar
  2. Domdey H, Wiebauer K, Kazmaier M, Muller V, Odink K, Fey G (1982) Characterization of the mRNA and cloned cDNA specifying the third component of mouse complement. Proc Natl Acad Sci (USA) 79: 7619–7623CrossRefGoogle Scholar
  3. Erdei A, Melchers F, Schulz TF, Dierich M (1985) The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes. Eur J Immunol 15: 184–188PubMedCrossRefGoogle Scholar
  4. Fearon DT (1984) Cellular receptors for fragments of the third component of complement. Immun Today 5: 105–110CrossRefGoogle Scholar
  5. Harada N, Kikuchi Y, Tominaga A, Takaki S, Takatsu K (1985) BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12). J Immunol 134: 3944–3951PubMedGoogle Scholar
  6. Howard M, Mizel SB, Lachman L, Ansel J, Johnson B, Paul WE (1983) Role of Interleukin I in anti-immunoglobulin induced B cell proliferation. J Exp Med 157: 1529–1543PubMedCrossRefGoogle Scholar
  7. Iscove NN, Melchers F (1978) Complete replacement of serum by albumin, transferrin and soybean lipid in cultures of LPS-reactive B lymphocytes. J Exp Med 147: 923–933PubMedCrossRefGoogle Scholar
  8. Lambris JD, Vishwas SG, Hirani S, Muller-Eberhard HJ (1985) Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement. Proc Natl Acad Sci (USA) 82: 4235–4239CrossRefGoogle Scholar
  9. Lernhardt W, Corbel C, Wall R, Melchers F (1982) T cell hybridomas which produce B lymphocyte replication factor only. Nature 300: 355–357PubMedCrossRefGoogle Scholar
  10. Lernhardt W, Corbel C, Melchers F, Wall R (1984) Functional and molecular characterization of murine B cell replication factor derived from a T cell hybridoma. In: Cantor H, Chess L, Sercarz E (eds) Regulation of the immune system. Alan R. Liss, Inc, New York, pp 573–581Google Scholar
  11. Lomedico PT, Gubler U, Hellmann CP, Dukowich M, Giri JG, Yu-ching EP, Collier K, Semionbw R, Chua AO, Mizel SB (1984) Cloning and expression of murine interleukin-1 cDNA in E. coli. Nature 312: 458–462PubMedCrossRefGoogle Scholar
  12. Lundval1 A, Wetsel RA, Domdey H, Tach BF, Fey GH (1984) Structure of murine complement component C3. I. Nucleotide sequence of cloned complementary and genomic DNA coding for the 3 chain. J Biol Chem 259: 13851–13856Google Scholar
  13. Melchers F, Lernhardt W (1985) Three restriction points in the cell cycle of activated murine B lymphocytes. Proc Natl Acad Sci (USA) 82: 355–357CrossRefGoogle Scholar
  14. Miller RG, Phillips RA (1969) Separation of cells by velocity sedimentation. J Cell Physiol 73: 191–202PubMedCrossRefGoogle Scholar
  15. Nemerow GR, McNaughton ME, Cooper NR (1985) Binding of monoclonal antibody to the Epstein Barr Virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes. J Immunol 135: 3068–3073PubMedGoogle Scholar
  16. Pike BL, Nossal GJV (1985) Interleukin I can act as a B-cell growth and differentiation factor. Proc Natl Acad Sci (USA) 82: 8153–8157CrossRefGoogle Scholar
  17. Swain SL, Howard M, Kappler J, Marrack P, Watson J, Booth R, Wetsel GD, Dutton R (1983) Evidence for two distinct classes of murine B-cell growth factors with activities in different functional assays. J Exp Med 158: 822–835PubMedCrossRefGoogle Scholar
  18. Thomas PS (1980) Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci (USA) 77: 5201–5205CrossRefGoogle Scholar
  19. Wetsel RA, Lundvall A, Davidson F, Gibson T, Tach BF, Fey GH (1984) Structure of murine complement component C3. II. Nucleotide sequence of cloned complementary DNA coding for the a chain. J Biol Chem 259: 13857–13862Google Scholar
  20. Wiebauer K, Domdey H, Diggelmann H, Fey G (1982) Isolation and analysis of genomic DNA clones encoding the third component of mouse complement. Proc Natl Acad Sci (USA) 79: 7077–7081CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1986

Authors and Affiliations

  • Waldemar Lernhardt
    • 1
  • William C. Raschke
    • 1
  • Fritz Melchers
    • 2
  1. 1.Cancer Research CenterLa Jolla Cancer Research FoundationLa JollaUSA
  2. 2.Basel Institute for ImmunologyBaselSwitzerland

Personalised recommendations